Impact of the New American and British guidelines on the management and treatment of dyslipidemia in a Spanish working population;Impacto de las nuevas guías estadounidense y británica en el manejo y el tratamiento de las dislipemias en una población laboral española

Revista Espanola de Cardiologia

Volumn 67, Issue 11, 2014, Pages 906-911

  Brotons, Carlos ^a,b   Calvo Bonacho, Eva ^c   Moral, Irene ^a,b   García Margallo, María Teresa ^d   Cortés Arcas, María Victoria ^d   Puig, Mireia ^a,b   Vázquez Pirillo, Gastón ^a,b   Ruilope, Luis Miguel ^e  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b Unidad Docente ACEBA   (Spain)

^c Ibermutuamur   (Spain)

^d Sociedad de Prevencion de Ibermutuamur   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cardiovascular diseases; Cardiovascular drugs; Clinical practice guidelines

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTILIPEMIC AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; CORONARY RISK; DYSLIPIDEMIA; FEMALE; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; RISK ASSESSMENT; SPANIARD; UNITED KINGDOM; UNITED STATES; CORONARY DISEASE; DYSLIPIDEMIAS; RISK FACTOR; SPAIN;

ADULT; CORONARY DISEASE; DYSLIPIDEMIAS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; MALE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SPAIN;

EID: 84908271185     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.06.020     Document Type: Article

References (16)

1. Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, and O. Wiklund ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J. 32 2011 1769 1818
2. J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, and M. Verschuren European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) Eur Heart J. 33 2012 1635 1701
3. M. Anguita, E. Alegría, V. Barrios, J.A. Casasnovas, C. Escobar, and M. León Comentarios a las guías de práctica clínica sobre manejo de las dislipemias de la Sociedad Europea de Cardiología y la Sociedad Europea de Aterosclerosis 2011. Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología Rev Esp Cardiol. 64 2011 1090 1095
4. M.A. Royo-Bordonada, J.M. Lobos Bejarano, F. Villar Alvarez, S. Sans, A. Pérez, and J. Pedro-Botet Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las guías europeas de prevención cardiovascular 2012 Rev Esp Salud Pública. 87 2013 103 120
5. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Merz, C.B. Blum, and R.H. Eckel 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation. 129 25 Suppl 2 2014 S1 S45
6. National Institute for Health and Care Excellence. Lipid modification. Cardiovascular risk assessment and the modifications of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE guideline. Draft for consultation, February 2014 [citado 25 Mar 2014]. Disponible en: http://www.nice.org.uk/nicemedia/live/13637/66552/66552.pdf
7. M.J. Pencina, A.M. Navar-Boggan, R.B. D'Agostino Sr., K. Williams, B. Neely, and A.D. Sniderman Application of new cholesterol guidelines to a population-based sample N Engl J Med. 370 2014 1422 1431
8. J. Vaucher, P. Marques-Vidal, M. Preisig, G. Waeber, and P. Vollenweider Population and economic impact of the 2013 ACC/AHA guidelines compared with European guidelines to prevent cardiovascular disease Eur Heart J. 35 2014 958 959
9. A. Cordero, R. López-Palop, V. Bertomeu-González, P. Carrillo, J. Moreno-Arribas, and V. Bertomeu-Martínez Perfil clínico y pronóstico de los pacientes con síndrome coronario agudo y colesterol unido a lipoproteínas de baja densidad < 70 mg/dl Rev Esp Cardiol. 66 2013 588 589
10. L. Pérez de Isla, A. Saltijeral Cerezo, G. Vitale, B. González Timón, A. Torres do Rego, and L.A. Alvarez-Sala Walther Cifras de colesterol adecuadas en pacientes coronarios y diabéticos. Análisis según especialidades médicas y comunidades autónomas Rev Esp Cardiol. 66 2013 748 749
11. M.A. Sánchez-Chaparro, J. Román-García, E. Calvo-Bonacho, T. Gómez-Larios, A. Fernández-Meseguer, and J.C. Sáinz-Gutiérrez Prevalencia de factores de riesgo vascular en la población laboral española Rev Esp Cardiol. 59 2006 421 430
12. R. Conroy, K. Pyörälä, A.P. Fitzgerald, S. Sans, A. Menotti, G. De Backer SCORE project group Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J. 24 2003 987 1003
13. J. Hippisley-Cox, C. Coupland, J. Robson, and P. Brindle Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database BMJ. 341 2010 c6624 10.1136/bmj.c6624
14. D.C. Goff Jr., D.M. Lloyd-Jones, G. Bennett, S. Coady, R.B. D'Agostino Sr., and R. Gibbons 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation. 129 2014 S49 S73
15. K.K. Ray, J.J. Kastelein, S.M. Boekholdt, S.J. Nicholls, K.-T. Khaw, and C.M. Ballantyne The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good, the bad, and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011 Eur Heart J. 35 2014 960 968
16. Divyang Shah Healthy worker effect phenomenon Indian J Occup Environ Med. 13 2009 77 79